Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
Type 2 diabetes (T2D) is a disease of pandemic proportions, one defined by a complex aetiological mix of genetic, epigenetic, environmental, and lifestyle risk factors. Whilst the last decade of T2D genetic research has identified more than 100 loci showing strong statistical association with diseas...
Auteurs principaux: | Beer, N, Gloyn, A |
---|---|
Format: | Journal article |
Publié: |
F1000Research
2016
|
Documents similaires
-
Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology [version 1; referees: 2 approved]
par: Nicola L. Beer, et autres
Publié: (2016-07-01) -
Enhanced osteogenic potential of iPSC-derived mesenchymal progenitor cells following genome editing of GWAS variants in the RUNX1 gene
par: Nazir M. Khan, et autres
Publié: (2024-12-01) -
Editorial: Genome editing in stem cells
par: Delger Bayarsaikhan, et autres
Publié: (2024-01-01) -
A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function
par: Grotz, A, et autres
Publié: (2019) -
Genome editing: from tools to biological insights
par: Yixin Yao
Publié: (2018-11-01)